Surabgene Lomparvovec
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Surabgene Lomparvovec, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) [Phase 3]